Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Morishita Jintan

森下仁丹

4524 · TSE · Pharmaceutical

Financials Consolidated

Revenue¥12.7bn−0.6% year on yearConsolidated · FY3/26

Ordinary profit¥773m−11.1% year on yearConsolidated · FY3/26

Net profit¥628m+14.8% year on yearConsolidated · FY3/26

Dividend per share¥65.00FY3/26

Performance over time

Revenue
¥9.56bnFY3/22
¥11.4bnFY3/23
¥12.4bnFY3/24
¥12.8bnFY3/25
¥12.7bnFY3/26
Ordinary profit
¥340mFY3/22
¥623mFY3/23
¥815mFY3/24
¥870mFY3/25
¥773mFY3/26
Net profit (attributable)
¥283mFY3/22
¥491mFY3/23
¥697mFY3/24
¥547mFY3/25
¥628mFY3/26
Op. cash flow
¥543mFY3/22
¥1.18bnFY3/23
¥196mFY3/24
¥669mFY3/25
¥1.15bnFY3/26

People & pay

Employees, whole group359 peopleFY3/26

Employees, parent company (non-consolidated)344 peopleFY3/26

Average salary¥6.35mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY3/26¥12.69bn−0.6% year on year¥773m¥628m¥153.53¥65.00¥18.6bn¥13.0bn¥1,150m
FY3/25¥12.77bn+2.9% year on year¥870m¥547m¥133.78¥55.00¥17.9bn¥12.2bn¥669m
FY3/24¥12.41bn+9.2% year on year¥815m¥697m¥170.68¥50.00¥17.2bn¥12.1bn¥196m
FY3/23¥11.36bn+18.8% year on year¥623m¥491m¥120.55¥40.00¥16.1bn¥11.4bn¥1,179m
FY3/22¥9.56bn¥340m¥283m¥69.58¥37.50¥14.5bn¥10.5bn¥543m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YE3I · Japan GAAP. Each figure's years come from one report's five-year summary.